Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Merck (MRK) reported Net Equity Issued and Repurchased of $43 million for Q2 2026, up 258.3% from $12 million a year earlier but down 72.6% from the prior quarter.

Analysis

Merck (MRK) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Merck's Net Equity Issued and Repurchased came in at $261 million, up 443.8% year-over-year; for FY2025, it was $92 million, down 48.0% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $177 million in FY2024 (+41.6%), $125 million in FY2023 (-67.4%), $384 million in FY2022 (+90.1%) and $202 million in FY2021 (+127.0%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $5 million in Q3 2024 and a high of $265 million in Q4 2022.
  • Year over year, Net Equity Issued and Repurchased has now increased in each of the last four quarters, with growth averaging 170.8% over the last eight quarters.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2026 (growth of 726.3%); the low point was Q4 2023 (a decline of 97.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $157 million (Q1 2026), $47 million (Q4 2025) and $14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 138.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -9.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 6.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -346.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -421.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -714.00 Mn
Mar 31, 2026 -717.00 Mn
Dec 31, 2025 -1.21 Bn
Sep 30, 2025 -1.31 Bn
Jun 30, 2025 -1.33 Bn
Mar 31, 2025 -1.15 Bn
Dec 31, 2024 -477.00 Mn
Sep 30, 2024 -439.00 Mn
Jun 30, 2024 -178.00 Mn
Mar 31, 2024 -35.00 Mn
Dec 31, 2023 -387.00 Mn
Sep 30, 2023 -459.00 Mn
Jun 30, 2023 -256.00 Mn
Mar 31, 2023 -119.00 Mn
Dec 31, 2022 265.00 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 97.00 Mn
Mar 31, 2022 12.00 Mn
Dec 31, 2021 116.00 Mn
Sep 30, 2021 -566.00 Mn
API Access

Merck Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MRK&period=max&api_key=YOUR_API_KEY